BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7684860)

  • 1. The treatment of painful osseous metastases with phosphorus-32-labeled phosphates.
    Silberstein EB
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):10-21. PubMed ID: 7684860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
    Pandit-Taskar N; Batraki M; Divgi CR
    J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
    Flamm J; Burkert S
    Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
    Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
    J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teletherapy and radiopharmaceutical therapy of painful bone metastases.
    Silberstein EB
    Semin Nucl Med; 2005 Apr; 35(2):152-8. PubMed ID: 15765378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [32P] diphosphonate dose determination in patients with bone metastases from prostatic carcinoma.
    Potsaid MS; Irwin RJ; Castronovo FP; Prout GR; Harvey WJ; Francis MD; Tofe AJ; Zamenhof RG
    J Nucl Med; 1978 Jan; 19(1):98-104. PubMed ID: 413889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma of the prostate: the treatment of bone metastases by radioactive phosphorus (32P).
    Ariel IM; Hassouna H
    Int Surg; 1985; 70(1):63-6. PubMed ID: 4019087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
    Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
    J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiopharmaceuticals for the palliation of painful bone metastases.
    Sinclair JM
    Am J Hosp Palliat Care; 2005; 22(5):338. PubMed ID: 16225354
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of strontium-89 systemic radiotherapy in the management of osseous metastases from prostate cancer.
    Soffen EM; Greenberg A; Baumann J; Corn BW
    Tech Urol; 1997; 3(2):76-80. PubMed ID: 9297766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiopharmaceuticals in clinical trials.
    Holmes RA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorus-32 radiopharmaceuticals for the treatment of painful osseous metastases.
    Silberstein EB; Elgazzar AH; Kapilivsky A
    Semin Nucl Med; 1992 Jan; 22(1):17-27. PubMed ID: 1589802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Palliative radiophosphorus therapy for analgesia in bone metastases].
    Grossmann J; Deckart H; Weiss M
    Radiobiol Radiother (Berl); 1988; 29(6):735-6. PubMed ID: 2473483
    [No Abstract]   [Full Text] [Related]  

  • 15. 89Strontium in the management of painful sceletal metastases.
    Kälkner KM; Westlin JE; Strang P
    Anticancer Res; 2000; 20(2B):1109-14. PubMed ID: 10810404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic curietherapy with P-32 in bone metastases in breast cancer].
    Navarro-Izquierdo AL; Baringo T; Domínguez J; Duque JJ; Martínez Comín L; Solsona F
    Rev Esp Oncol; 1980; 27(1):101-6. PubMed ID: 6163183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radionuclide therapy of bone metastases: prospects for enhancement of therapeutic efficacy.
    Mertens WC
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):49-55. PubMed ID: 7684866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage and response in radiopharmaceutical therapy of painful osseous metastases.
    Silberstein EB
    J Nucl Med; 1996 Feb; 37(2):249-52. PubMed ID: 8667054
    [No Abstract]   [Full Text] [Related]  

  • 19. Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic.
    Kirou-Mauro AM; Hird A; Wong J; Sinclair E; Barnes EA; Tsao M; Danjoux C; Chow E
    J Pain Symptom Manage; 2009 Jan; 37(1):77-84. PubMed ID: 18504094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is response to radiotherapy in patients related to the severity of pretreatment pain?
    Kirou-Mauro A; Hird A; Wong J; Sinclair E; Barnes EA; Tsao M; Danjoux C; Chow E
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1208-12. PubMed ID: 18572084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.